Featured Editorial

1. Electronic Drug Delivery Devices Market: Advancing Smart, Connected Healthcare 12/19/2025

   What is factoring into market growth for electronic drug delivery devices and why? New market research shares key insights.

2. Regulating For Patient Safety And Success With Combination Products 12/16/2025

   At the AFDO/RAPS Combination Products Summit 2025, a notable focus emerged around approaches to risk assessment and human factors studies. In this article, Chief Editor Tom von Gunden offers his appreciation for the biopharma industry’s consideration of patient usability and safety in the development and regulation of combination products and other drug delivery devices. 

3. FDA Issues Final Guidance For pH Adjuster Waiver Requests For Generic Drugs 12/11/2025

   The FDA has issued a final guidance, Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use.

4. Strained Manufacturing, Complexity Stymie In Vivo Progress 12/4/2025

    Explicitly mapping delivery challenges to the associated GMP process steps converts biological risk into operational risk.

5. To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem 12/4/2025

   The choice of delivery dictates the complexity of manufacturing, which in turn determines the eventual cost and accessibility of the therapy.

6. Is Oncology Precision Medicine Coming of Age? 12/3/2025

   Developers are releasing new data suggesting that their targeted therapy candidates may finally address some of oncology’s toughest challenges.

7. Drug Delivery Trends From 2025: Top 4 For Momentum Gains In 2026 12/2/2025

   In this article, Fran DeGrazio identifies four notable trends in drug delivery that gained momentum in 2025 and, she predicts, will continue to do so in 2026 and beyond. They are digitalization, sustainability, patient centricity, and the advanced delivery of complex biopharmaceuticals.

8. The Blue Crayfish: Turning Nature's Efficiency Into Safe, Bioavailable Therapeutics 12/1/2025

   Crayfish achieve incredibly rapid biomineralization — a physiological marvel that is now setting the stage for a new class of highly bioavailable mineral-based therapeutic agents.

9. Formulation And Delivery Considerations For Cell And Gene Therapies 11/25/2025

   How can we ensure cell and gene therapies are truly transformative for patients? Success depends on the right combination of formulation, preparation, and delivery.

10. Emerging RNA Delivery Strategies For Solid Tumor Oncology 11/20/2025

    RNA shows promise in solid tumors, but delivery remains the core challenge. New targeting and delivery strategies aim to overcome tumor barriers and unlock RNA’s full therapeutic potential.